Sex differences in LDL-C response to PCSK9 inhibitors: A real world experience
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sex differences in LDL-C response to PCSK9 inhibitors: A real world experience
Authors
Keywords
-
Journal
Journal of Clinical Lipidology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-12-08
DOI
10.1016/j.jacl.2022.12.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sex differences in low-density lipoprotein cholesterol reduction with PCSK9 inhibitors in real world patients
- (2022) Alberto Cordero et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2021) Glen J. Pearson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience
- (2021) Rodrigo Alonso et al. Journal of Clinical Lipidology
- Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction
- (2021) Calvin L. Colvin et al. Journal of Clinical Lipidology
- LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments
- (2021) Christos V. Rizos et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Six years’ experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias
- (2020) Jacqueline S. Dron et al. BMC Medical Genomics
- Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care
- (2020) Sujana Balla et al. Current Atherosclerosis Reports
- Proprotein convertase subtilisin/kexin type 9 inhibitor utilization and low-density lipoprotein-cholesterol control in familial hypercholesterolemia
- (2020) Candace L. Jackson et al. Journal of Clinical Lipidology
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipid Lowering Therapy and Circulating PCSK9 Concentration
- (2017) Tsuyoshi Nozue Journal of Atherosclerosis and Thrombosis
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia
- (2016) Leopoldo Perez de Isla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- Relationship between testosterone, estradiol and circulating PCSK9: Cross-sectional and interventional studies in humans
- (2015) T.C. Ooi et al. CLINICA CHIMICA ACTA
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
- (2015) Sue Richards et al. GENETICS IN MEDICINE
- PCSK9 deficiency unmasks a sex- and tissue-specific subcellular distribution of the LDL and VLDL receptors in mice
- (2015) Anna Roubtsova et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein (a): impact by ethnicity and environmental and medical conditions
- (2015) Byambaa Enkhmaa et al. JOURNAL OF LIPID RESEARCH
- The Effects of Estrogen on Serum Level and Hepatocyte Expression of PCSK9
- (2015) Wen Guo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol
- (2014) Moumita Ghosh et al. JOURNAL OF LIPID RESEARCH
- Meta-analysis of Comparative Efficacy of Increasing Dose of Atorvastatin Versus Rosuvastatin Versus Simvastatin on Lowering Levels of Atherogenic Lipids (from VOYAGER)
- (2009) Stephen J. Nicholls et al. AMERICAN JOURNAL OF CARDIOLOGY
- Genetic and Metabolic Determinants of Plasma PCSK9 Levels
- (2009) Susan G. Lakoski et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started